Literature DB >> 8475934

Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease.

B W Berg1, T A Dillard, S S Derderian, K R Rajagopal.   

Abstract

PURPOSE: Cardiovascular events are the leading cause of death during air travel. Because patients with chronic obstructive pulmonary disease (COPD) develop severe hypoxemia at altitude, we sought to determine whether changes in systemic hemodynamics may contribute to health risks during hypobaric hypoxia. PATIENTS AND METHODS: We recorded radial artery catheter blood pressure, cardiac frequency, and cardiac ectopy in 18 men (aged 68 +/- 6 years, mean +/- SD) with severe COPD (forced expiratory volume in 1 second 0.97 L +/- 0.32 L) at sea level, after 45 minutes of steady-state hypobaric hypoxia at 2,438 m in a hypobaric chamber, and after oxygen supplementation at 2,438 m.
RESULTS: Mean arterial pressure (mm Hg), systolic blood pressure (SBP), diastolic blood pressure, and pulsus paradoxus during acute hypobaric exposure did not differ from baseline. During oxygen supplementation, SBP declined (p = 0.028). Decreases in pulsus paradoxus and pulse pressure were noted on oxygen (p < 0.05). We found no changes in cardiac frequency. Cardiac ectopy was uncommon; for one subject, ectopy increased with hypobaric hypoxia and decreased with oxygen administration.
CONCLUSION: Vasopressor responses to hypoxia do not add to the risk of air travel in patients with severe COPD. Supplemental oxygen may cause beneficial hemodynamic changes in patients with COPD during acute hypobaric exposure.

Entities:  

Mesh:

Year:  1993        PMID: 8475934     DOI: 10.1016/0002-9343(93)90152-f

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations.

Authors: 
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

2.  Changes in cardiac output during air ambulance repatriation.

Authors:  I Malagon; R M Grounds; E D Bennett
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

3.  Effects of commercial air travel on patients with pulmonary hypertension air travel and pulmonary hypertension.

Authors:  Nareg Roubinian; C Gregory Elliott; Christopher F Barnett; Paul D Blanc; Joan Chen; Teresa De Marco; Hubert Chen
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

Review 4.  [Air travel and respiratory diseases].

Authors:  Francisco García Río; Luis Borderías Clau; Ciro Casanova Macario; Bartolomé R Celli; Joan Escarrabill Sanglás; Nicolás González Mangado; Josep Roca Torrent; Fernando Uresandi Romero
Journal:  Arch Bronconeumol       Date:  2007-02       Impact factor: 4.872

Review 5.  Chronic obstructive pulmonary disease * 11: fitness to fly with COPD.

Authors:  A O C Johnson
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

6.  Respiratory function and blood gas variables in cystic fibrosis patients during reduced environmental pressure.

Authors:  Oliver Thews; Birthe Fleck; Wolfgang E S Kamin; Dirk-Matthias Rose
Journal:  Eur J Appl Physiol       Date:  2004-08       Impact factor: 3.078

7.  Blood pressure response to exposure to moderate altitude in patients with COPD.

Authors:  Esther I Schwarz; Tsogyal D Latshang; Michael Furian; Deborah Flück; Sebastian Segitz; Severine Müller-Mottet; Silvia Ulrich; Konrad E Bloch; Malcolm Kohler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-03-14

8.  BTS Clinical Statement on air travel for passengers with respiratory disease.

Authors:  Robina Kate Coker; Alison Armstrong; Alistair Colin Church; Steve Holmes; Jonathan Naylor; Katharine Pike; Peter Saunders; Kristofer John Spurling; Pamela Vaughn
Journal:  Thorax       Date:  2022-02-28       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.